These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 28338199)
21. The deregulation of miR-133b is associated with poor prognosis in bladder cancer. Shi Z; Kadeer A; Wang M; Wen B; Li M; Huang J; Gao Y; Liu E; Liu D; Jia D; Liang C Pathol Res Pract; 2019 Feb; 215(2):354-357. PubMed ID: 30591241 [TBL] [Abstract][Full Text] [Related]
22. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival. Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781 [TBL] [Abstract][Full Text] [Related]
23. Evaluation of miR-302c-3p as prognostic biomarkers in glioma patients. Zheng GD; Wang YU; Zhu XD Eur Rev Med Pharmacol Sci; 2016 Apr; 20(8):1521-5. PubMed ID: 27160124 [TBL] [Abstract][Full Text] [Related]
24. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma. Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727 [TBL] [Abstract][Full Text] [Related]
25. Downregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladder. Chen X; Wu B; Xu Z; Li S; Tan S; Liu X; Wang K Cancer Med; 2016 Aug; 5(8):1856-62. PubMed ID: 27292588 [TBL] [Abstract][Full Text] [Related]
26. Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer. Wang S; Li Q; Wang K; Dai Y; Yang J; Xue S; Han F; Zhang Q; Liu J; Wu W Clin Transl Oncol; 2013 Oct; 15(10):849-54. PubMed ID: 23408039 [TBL] [Abstract][Full Text] [Related]
27. Low expression of miR-597 is correlated with tumor stage and poor outcome in breast cancer. Zhang XY; Liu DJ; Yuan RB; Zhang DH; Li SR; Zhang SH; Zhang LY Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):456-460. PubMed ID: 29424903 [TBL] [Abstract][Full Text] [Related]
28. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Yang J; Liu H; Wang H; Sun Y Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213 [TBL] [Abstract][Full Text] [Related]
29. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients. Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406 [TBL] [Abstract][Full Text] [Related]
30. Down-regulation of miR-329-3p is associated with worse prognosis in patients with cervical cancer. Chang YH; Yin F; Fan GF; Zhao M Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4045-4049. PubMed ID: 29028098 [TBL] [Abstract][Full Text] [Related]
31. miR-144-3p serves as a tumor suppressor by targeting FZD7 and predicts the prognosis of human glioblastoma. Cheng ZX; Song YX; Wang ZY; Wang Y; Dong Y Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4079-4086. PubMed ID: 29028093 [TBL] [Abstract][Full Text] [Related]
32. Prognostic value of miR-141 downregulation in gastric cancer. Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225 [TBL] [Abstract][Full Text] [Related]
33. Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer. Xu S; Yi XM; Zhou WQ; Cheng W; Ge JP; Zhang ZY Int J Clin Exp Pathol; 2015; 8(11):14335-44. PubMed ID: 26823749 [TBL] [Abstract][Full Text] [Related]
34. MicroRNA-211 expression is down-regulated and associated with poor prognosis in human glioma. Zhang J; Lv J; Zhang F; Che H; Liao Q; Huang W; Li S; Li Y J Neurooncol; 2017 Jul; 133(3):553-559. PubMed ID: 28551850 [TBL] [Abstract][Full Text] [Related]
35. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer. Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306 [TBL] [Abstract][Full Text] [Related]
36. Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer. Jiang X; Du L; Duan W; Wang R; Yan K; Wang L; Li J; Zheng G; Zhang X; Yang Y; Wang C Oncotarget; 2016 Jun; 7(24):36733-36742. PubMed ID: 27167342 [TBL] [Abstract][Full Text] [Related]
37. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients. Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857 [TBL] [Abstract][Full Text] [Related]
38. Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer. Jiang X; Du L; Wang L; Li J; Liu Y; Zheng G; Qu A; Zhang X; Pan H; Yang Y; Wang C Int J Cancer; 2015 Feb; 136(4):854-62. PubMed ID: 24961907 [TBL] [Abstract][Full Text] [Related]
39. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer. Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197 [TBL] [Abstract][Full Text] [Related]
40. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma. Liu W; Zhao ZY; Shi L; Yuan WD Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]